Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 3:05 pm Sale |
2025-03-31 | 13G | Denali Therapeutics Inc. DNLI |
BLACKROCK INC BLK |
10,490,610 7.200% |
-3,297,263 (-23.91%) |
Filing History |
| 2025-04-17 09:35 am Purchase |
2025-03-31 | 13G | Nutanix, Inc. NTNX |
BLACKROCK INC BLK |
16,378,030 6.100% |
16,378,030 (New Position) |
Filing History |
| 2025-02-13 2:14 pm Sale |
2024-12-31 | 13G | Denali Therapeutics Inc. DNLI |
Capital Research Global Investors | 5,477,211 3.800% |
-2,431,903 (-30.75%) |
Filing History |
| 2025-02-12 10:52 am Sale |
2024-12-31 | 13G | Denali Therapeutics Inc. DNLI |
BAILLIE GIFFORD & CO | 12,313,931 8.600% |
-1,946,793 (-13.65%) |
Filing History |
| 2024-11-12 12:52 pm Purchase |
2024-11-07 | 13G | Denali Therapeutics Inc. DNLI |
Capital Research Global Investors | 7,909,114 5.500% |
7,909,114 (New Position) |
Filing History |
| 2024-11-12 09:55 am Purchase |
2024-11-08 | 13G | Denali Therapeutics Inc. DNLI |
FMR CORP | 10,141,901 7.084% |
2,949,956 (+41.02%) |
Filing History |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Denali Therapeutics Inc. DNLI |
BLACKROCK INC BLK |
13,787,873 9.600% |
0 (Unchanged) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Denali Therapeutics Inc. DNLI |
WELLINGTON MANAGEMENT CO LLP | 10,727,450 7.490% |
3,452,733 (+47.46%) |
Filing History |
| 2024-11-07 4:48 pm Sale |
2024-10-30 | 13G | Denali Therapeutics Inc. DNLI |
BIOGEN IDEC INC BIIB |
7,155,243 4.970% |
-5,596,122 (-43.89%) |
Filing History |
| 2024-10-21 4:11 pm Purchase |
2024-09-30 | 13G | Denali Therapeutics Inc. DNLI |
BLACKROCK INC BLK |
13,787,873 9.600% |
2,245,012 (+19.45%) |
Filing History |
| 2024-08-16 1:18 pm Purchase |
2024-08-15 | 13G | Denali Therapeutics Inc. DNLI |
FMR CORP | 7,191,945 5.023% |
1,337,910 (+22.85%) |
Filing History |
| 2024-02-13 5:02 pm Purchase |
2023-12-29 | 13G | Denali Therapeutics Inc. DNLI |
The Vanguard Group | 10,834,483 7.840% |
887,385 (+8.92%) |
Filing History |
| 2024-02-13 4:27 pm Sale |
2023-12-31 | 13G | Denali Therapeutics Inc. DNLI |
BRATTON DOUGLAS K | 5,750,882 4.200% |
-1,250,000 (-17.85%) |
Filing History |
| 2024-02-12 7:07 pm Sale |
2023-12-31 | 13G | Denali Therapeutics Inc. DNLI |
BIOGEN IDEC INC BIIB |
12,751,365 9.230% |
-558,878 (-4.20%) |
Filing History |
| 2024-02-08 10:11 am Purchase |
2023-12-29 | 13G | Denali Therapeutics Inc. DNLI |
WELLINGTON MANAGEMENT CO LLP | 7,274,717 5.260% |
7,274,717 (New Position) |
Filing History |
| 2024-01-30 06:59 am Sale |
2023-12-29 | 13G | Denali Therapeutics Inc. DNLI |
BAILLIE GIFFORD & CO | 14,260,724 10.320% |
-858,750 (-5.68%) |
Filing History |
| 2024-01-30 06:40 am Unchanged |
2023-12-31 | 13G | Denali Therapeutics Inc. DNLI |
TEMASEK HOLDINGS LTD | 6,895,992 4.900% |
0 (Unchanged) |
Filing History |
| 2024-01-25 4:59 pm Purchase |
2023-12-31 | 13G | Denali Therapeutics Inc. DNLI |
BLACKROCK INC BLK |
11,542,861 8.400% |
2,221,432 (+23.83%) |
Filing History |
| 2023-03-30 06:14 am Purchase |
2023-03-23 | 13G | Denali Therapeutics Inc. DNLI |
TEMASEK HOLDINGS LTD | 6,895,992 5.000% |
6,895,992 (New Position) |
Filing History |
| 2023-02-13 4:14 pm Sale |
2022-12-31 | 13G | Denali Therapeutics Inc. DNLI |
BRATTON DOUGLAS K | 7,000,882 5.200% |
-844,307 (-10.76%) |
Filing History |